Aphton Corp. of Woodland, Calif., said Wednesday that it plansto apply next month for approval to start clinical trials onpatients with metastatic colon cancer in the United Kingdom.

The company also said it spent more than $2 million onresearch and development in the fiscal year ending April 30,accomplishing all of its R&D objectives.

(c) 1997 American Health Consultants. All rights reserved.